The Imperial College AHSC vision is to reduce the burden of human disease by accelerating the translation of basic science discoveries into patient and population health benefit. By aligning the partners’ expertise, the AHSC aims to deliver (inter-) nationally leading infrastructure and programmes in health research, education and clinical care.
The underpinning principles for the Imperial College AHSC are to:
- Use research and education as the drivers for improving patient outcomes and population health, and
- Add value to the partner’s missions through collaborations that capitalise on the academic strengths of Imperial College London and the critical mass and clinical capabilities of the NHS partners.
To underpin its vision, the AHSC strategy is to:
- Focus on diseases of major public health burden in the UK over the next 15-20 years
- Establish AHSC informatics capability to underpin data driven solutions for improved patient care and population health
- Cultivate programmes in disease prevention to reduce disease incidence, recurrence and hospital admissions
- Identify and develop technologies for earlier detection of disease by pulling through, to clinical application, Imperial discovery science in engineering, chemistry, physics, data science, biology & medicine
- Improve treatment options through clinical-academic development and evaluation of new, targeted and more cost effective approaches
- Develop the clinical workforce across all partners.
The current AHSC priority programmes are:
- Prevention and early detection of cancer
- Health informatics
- Artificial intelligence approaches to clinical diagnosis
The AHSC partners are focused on these because of the expertise, experience and existing collaborations that they already have to tackle them.